Evidence map›Paper›PMID 41145922›Full record

ReviewPediatric nephrology (Berlin, Germany)2026

A brief review of some artificial intelligence methods in nephrology.

Kevin V Lemley

Abstract readReview
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kevin V LemleyDepartment of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. klemley@chla.usc.edu.ORCID http://orcid.org/0000-0001-8342-5458

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This brief, focused review considers two of the more commonly used artificial intelligence (AI) methods encountered in nephrology publications: machine vision based on convolutional neural networks (CNNs) and chatbots, such as ChatGPT, based on large language models. It is intended to offer a mostly non-technical, intuitive understanding of these methods, including their uses and limitations. CNNs have been used for some time to segment and classify important features of digitized kidney biopsy images. In addition to the identification of pathologic primitives, CNN approaches may be used to predict so-called sub-visual features of biopsies, such as kidney survival rates. Large language models are newer players in the medical AI field. Although seemingly easy to use as natural language tools, most currently available chatbots have been characterized by inconsistent performance, hallucinations, and even a higher CO

Indexed as

Artificial IntelligenceKidneyKidney DiseasesNephrologyNeural Networks, ComputerBiopsyHumansChatbotComputational pathologyConvolutional neural netLarge language modelMachine learningNephropathology

Identifiers

PMID41145922
PMCPMC13139217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.